Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells

被引：0
|
作者：
Potenza, Alessia
Balestrieri, Chiara
Albarello, Luca
Pedica, Federica
Spiga, Martina
Manfredi, Francesco
Cianciotti, Beatrice C.
De lalla, Claudia
Stasi, Lorena
Tassi, Elena
Bonfiglio, Silvia
Scotti, Giulia M.
Redegalli, Miriam
Biancolini, Donatella
Abbati, Danilo
Simeoni, Fabio
Lazarevic, Dejan
Elmore, Ugo
Fiorentini, Guido
Di Lullo, Giulia
Casorati, Giulia
Doglioni, Claudio
Tonon, Giovanni
Dellabona, Paolo
Rosati, Riccardo
Aldrighetti, Luca
Ruggiero, Eliana
Bonini, Chiara
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
902
引用
收藏
页数：3
相关论文
共 50 条
  • [21] CD39 Expression in Peripheral T Cells is Associated with Clinicopathological Characteristics in Patients with Cervical Cancer
    Zhao, Kuo
    Han, Dongmei
    Tang, Lu
    Jin, Hao
    IRANIAN JOURNAL OF IMMUNOLOGY, 2023, 20 (03) : 276 - 286
  • [22] CD39 is a novel surface marker of murine regulatory T cells
    Dwyer, Karen
    Deaglio, Silvia
    Gao, Wenda
    Strom, Terry
    Robson, Simon
    IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : A28 - A29
  • [23] Colorectal cancer: The treatment of liver metastases
    Kemeny, N
    EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY - 21ST ESMO CONGRESS, EDUCATIONAL BOOK, 1996, : 31 - 33
  • [24] Treatment of liver metastases of colorectal cancer
    van de Velde, CJH
    ANNALS OF ONCOLOGY, 2005, 16 : 144 - 149
  • [25] Treatment of liver metastases of colorectal cancer
    Patutko, UI
    Sagaidak, IV
    Podluzhny, DV
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 230 - 231
  • [26] CD39: A new surface marker of mouse regulatory γδ T cells
    Otsuka, Atsushi
    Hanakawa, Sho
    Miyachi, Yoshiki
    Kabashima, Kenji
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (06) : 1448 - 1451
  • [27] Regulation of the T Cell Response by CD39
    Takenaka, Maisa C.
    Robson, Simon
    Quintana, Francisco J.
    TRENDS IN IMMUNOLOGY, 2016, 37 (07) : 427 - 439
  • [28] Engineered T cells for Colorectal Cancer
    Bakarurraini, Nurul Ainaa Adilah Rus
    Kamarudin, Ammar Akram
    Jamal, Rahman
    Abu, Nadiah
    IMMUNOTHERAPY, 2024, 16 (14-15) : 987 - 998
  • [29] CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
    Gupta, Prakash K.
    Godec, Jernej
    Wolski, David
    Adland, Emily
    Yates, Kathleen
    Pauken, Kristen E.
    Cosgrove, Cormac
    Ledderose, Carola
    Junger, Wolfgang G.
    Robson, Simon C.
    Wherry, E. John
    Alter, Galit
    Goulder, Philip J. R.
    Klenerman, Paul
    Sharpe, Arlene H.
    Lauer, Georg M.
    Haining, W. Nicholas
    PLoS Pathogens, 2015, 11 (10)
  • [30] Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
    Clayton, Aled
    Al-Taei, Saly
    Webber, Jason
    Mason, Malcolm D.
    Tabi, Zsuzsanna
    JOURNAL OF IMMUNOLOGY, 2011, 187 (02): : 676 - 683
12345